Skip to content

Clinical trials

Completed Insulin Resistance trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Status: Completed Country / region: Singapore Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20131
20141
20181
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Human Development and Potential (IHDP), Singapore3
National University of Singapore3
Eli Lilly and Company1
Khoo Teck Puat Hospital1
National University Hospital, Singapore1
Singapore General Hospital1
Singapore Institute of Food and Biotechnology Innovation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance11
Obesity2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Glucose Intolerance1
Hyperglycemia1
Obesity, Morbid1
Prediabetic State1
Weight Loss1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.